NCT07218510
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07218510
Title Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Acronym LonGEVity
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center RECRUITING Duarte California 91010 United States Details
City of Hope at Irvine Lennar RECRUITING Irvine California 92618 United States Details
City of Hope at Long Beach Elm RECRUITING Long Beach California 90813 United States Details
University of Miami Miller School of Medicine-Sylvester Cancer Center NOT_YET_RECRUITING Miami Florida 33136 United States Details
City of Hope Atlanta Cancer Center RECRUITING Newnan Georgia 30265 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone NOT_YET_RECRUITING New York New York 10016 United States Details
Medical College of Wisconsin NOT_YET_RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field